|
George P. Canellos is an American oncologist and cancer researcher. His research career spans many decades as well as several areas of therapeutic agents for the treatment of malignant diseases. He is perhaps most known for his work with Vincent T. DeVita in which he developed the combination chemotherapy CMF,〔[http://www.ncbi.nlm.nih.gov/pubmed/1259283?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum Combination chemotherapy for advanced breast cance...[Ann Intern Med. 1976] - PubMed Result]〕 which was one of the first combination therapies for breast cancer. The two also collaborated to create the MOPP regimen for Hodgkin's lymphoma.〔DeVita V, Simon R, Hubbard S, Young R, Berard C, Moxley J, Frei E, Carbone P, Canellos G (1980). "Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.". Ann Intern Med 92 (5): 587-95. PMID 6892984〕 As former chair of the Lymphoma Committee of the Cancer and Leukemia Group B (CALGB), a national American cooperative trials group, Canellos initiated many practice-changing clinical trials of cancer therapies. He was also the Editor-in-Chief of the ''Journal of Clinical Oncology'' from 1988 to 2001. He is currently one of the senior clinicians at the Dana-Farber Cancer Institute and the Brigham and Women's Hospital as well as the William Rosenberg Professor of Medicine at Harvard Medical School. == References == 〔 Category:Living people Category:American oncologists Category:Cancer researchers Category:Harvard Medical School faculty Category:Harvard University alumni 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「George Canellos」の詳細全文を読む スポンサード リンク
|